Advertisement
EJVES Extra Abstract| Volume 44, ISSUE 4, P461, October 2012

Download started.

Ok

A Case of Septic Superficial Thrombophlebitis of Varicose Veins Associated with Yersinia enterocolitica and Propionibacterium

Open ArchivePublished:July 25, 2012DOI:https://doi.org/10.1016/j.ejvs.2012.06.026
      A patient with a history of varicose veins developed septic superficial thrombophlebitis in the great saphenous vein (GSV). Blood cultures grew Yersinia enterocolitica and Propionibacterium. Ultrasonography showed thrombus extending into the deep venous system, which exposed the patient to the risk of septic emboli. This risk, together with the contraindication to anticoagulation due to the patient's gastric erosions and ulceration, prompted the decision to surgically remove the thrombus. Although superficial thrombophlebitis is common in the setting of varicose veins, septic superficial thrombophlebitis is rare, especially due to Yersinia infection.

      Linked Article

      • A Case of Septic Superficial Thrombophlebitis of Varicose Veins Associated with Yersinia enterocolitica and Propionibacterium
        EJVES ExtraVol. 24Issue 3
        • Preview
          A patient with a history of varicose veins developed septic superficial thrombophlebitis in the great saphenous vein (GSV). Blood cultures grew Yersinia enterocolitica and Propionibacterium. Ultrasonography showed thrombus extending into the deep venous system, which exposed the patient to the risk of septic emboli. This risk, together with the contraindication to anticoagulation due to the patient's gastric erosions and ulceration, prompted the decision to surgically remove the thrombus. Although superficial thrombophlebitis is common in the setting of varicose veins, septic superficial thrombophlebitis is rare, especially due to Yersinia infection.
        • Full-Text
        • PDF
        Open Access

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.